Skip to Main Content
Contact Us
Category: Immuno-oncology therapies
Photo of Keya Watkins and Sue Albert at the SITC sign during the SITC conference. Key Insights from SITC 2024 Overcoming Cancer Resistance to Immunotherapy The Society for Immunotherapy of Cancer (SITC) is the premier Read Now Patient meeting with doctor who is taking notes with sunshine coming in from the background. Highlights from HubXchange Immunotherapies Maryland 2024 Optimizing Dose and Leveraging Biomarkers for Enhanced Patient Safety in Immunotherapy Trials HubXchange Immunotherapies brought Read Now Antibody drug conjugates with blue cells Helping to Bring Antibody Drug Conjugates (ADCs) to Patients  Catalyst Oncology is a specialty oncology contract research organization (CRO) devoting time, energy, and capital Read Now Helping to Bring Cancer Therapies to Patients  Niche CRO with a difference Catalyst Oncology is a niche oncology CRO devoting time, energy, Read Now Helping to Bring Immunotherapies to Cancer Patients in Need Catalyst Oncology is a specialty oncology clinical research organization (CRO) devoting time, energy, and capital Read Now